Variables | Control group | Atrial septal defect group | Ventricular septal defect group |
---|---|---|---|
N | 30 | 20 | 23 |
Gender (M/F) | 12/18 | 7/13 | 10/13 |
Age (y) | 39.87 ± 13.17 | 35.85 ± 14.12 | 38.30 ± 14.81 |
PH, N (%) | 0 | 15 (75%) | 6 (26.1%) |
NYHA Class (II/III) | 0 | 16/4 | 15/8 |
CPB time, min | – | 66 ± 28 | 75 ± 23 |
Aortic cross clamp time, min | – | 33 ± 24 | 39 ± 20 |
LAD, mm | 29.93 ± 2.69 | 33.75 ± 5.11* | 36.48 ± 9.98* |
LVEDD, mm | 45.903.16 | 39.75 ± 3.89* | 51.78 ± 11.43*# |
LVESD, mm | 28.80 ± 2.72 | 25.55 ± 2.87* | 31.64 ± 8.28# |
RAD, mm | 33.53 ± 3.67 | 46.42 ± 8.36* | 39.59 ± 11.93 |
RVD, mm | 19.30 ± 2.76 | 35.35 ± 8.65* | 22.22 ± 5.03# |
LVEF, % | 69.27 ± 6.60 | 66.65 ± 7.07 | 68.22 ± 5.87 |